Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India · Delayed Price · Currency is INR 78.39
+0.92 (1.19%)
At close: Jul 31, 2026
BOM:524412 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 13.99 | 14.73 | 15.94 | 7.06 | 1.92 |
Short-Term Investments | 19.99 | 17.56 | 12.95 | 4.18 | - |
Cash & Short-Term Investments | 33.98 | 32.29 | 28.9 | 11.24 | 1.92 |
Cash Growth | 5.22% | 11.75% | 157.15% | 485.62% | -70.46% |
Accounts Receivable | 1,297 | 1,335 | 1,845 | 1,898 | 1,363 |
Other Receivables | - | 4.11 | 0.33 | 0.33 | 1.3 |
Receivables | 1,503 | 1,634 | 2,000 | 1,988 | 1,364 |
Inventory | 415.36 | 716.86 | 719.94 | 651.79 | 561.16 |
Other Current Assets | 677.49 | 272.58 | 76.78 | 54.77 | 260.75 |
Total Current Assets | 2,629 | 2,656 | 2,826 | 2,706 | 2,188 |
Property, Plant & Equipment | 257.78 | 162.21 | 129.61 | 139.37 | 144.67 |
Long-Term Investments | 21.15 | 21.23 | 13.88 | 4.08 | 27.97 |
Other Long-Term Assets | 64.11 | 56.64 | 56.53 | 55.96 | 51.1 |
Total Assets | 2,972 | 2,906 | 3,033 | 2,913 | 2,452 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 815.89 | 1,025 | 1,289 | 1,273 | 1,097 |
Accrued Expenses | - | -35.26 | -1.74 | -11.44 | 3.67 |
Short-Term Debt | 597.75 | 415.62 | 281.28 | 333.58 | 108.23 |
Current Income Taxes Payable | 15.93 | 14.02 | 38.48 | 50.56 | 48.25 |
Other Current Liabilities | 21.2 | 72.27 | 58.03 | 35.4 | 10.6 |
Total Current Liabilities | 1,451 | 1,492 | 1,665 | 1,681 | 1,267 |
Long-Term Debt | 9.74 | 19.87 | 32.24 | 43.61 | 33.4 |
Long-Term Deferred Tax Liabilities | 7.73 | 9.19 | 7.49 | 14.15 | 14.55 |
Other Long-Term Liabilities | - | - | - | -0 | -0 |
Total Liabilities | 1,468 | 1,521 | 1,705 | 1,739 | 1,315 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 284.54 | 284.54 | 280.54 | 253.85 | 253.85 |
Additional Paid-In Capital | - | 501.79 | 489.28 | 410.84 | 410.84 |
Retained Earnings | - | 571.32 | 531.26 | 484.25 | 446.53 |
Comprehensive Income & Other | 1,220 | 27.15 | 26.65 | 25.15 | 25.15 |
Shareholders' Equity | 1,504 | 1,385 | 1,328 | 1,174 | 1,136 |
Total Liabilities & Equity | 2,972 | 2,906 | 3,033 | 2,913 | 2,452 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 607.49 | 435.49 | 313.52 | 377.18 | 141.63 |
Net Cash (Debt) | -573.51 | -403.2 | -284.63 | -365.94 | -139.71 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -20.16 | -14.27 | -11.20 | -14.36 | -5.80 |
Filing Date Shares Outstanding | 28.45 | 28.45 | 28.05 | 25.38 | 25.38 |
Total Common Shares Outstanding | 28.45 | 28.45 | 28.05 | 25.38 | 25.38 |
Working Capital | 1,179 | 1,164 | 1,160 | 1,025 | 920.81 |
Book Value Per Share | 52.86 | 48.67 | 47.33 | 46.25 | 44.77 |
Tangible Book Value | 1,504 | 1,385 | 1,328 | 1,174 | 1,136 |
Tangible Book Value Per Share | 52.86 | 48.67 | 47.33 | 46.25 | 44.77 |
Land | - | 3.79 | 3.79 | 3.79 | 3.79 |
Buildings | - | 46.15 | 39.12 | 39.12 | 39.01 |
Machinery | - | 341.02 | 296.01 | 288.79 | 278.46 |